Delivery Order SPE2DR25D3303-SPE2DR26F65M3
- Not listed
- The Defense Logistics Agency awarded a $14,704.98 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Erleada 240 mg tablets (30-count units) with a completion date of September 2, 2025. This non-competitive award represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The pharmaceutical distributor, headquartered in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $23,245.17 to AmerisourceBergen Drug Corp for the supply of Erleada 240 mg tablets in quantities of 30 units. This competitive award, issued on December 4, 2025, with an ultimate completion date of December 26, 2025, is structured as a firm fixed price delivery order with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Erleada 60 mg tablets (120-count units) under a firm fixed-price contract. The award, effective December 17, 2025, carries a ceiling value of $7,965.80 with an ultimate completion date of January 9, 2026. This is a non-set-aside, competitively awarded delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated...
- The Defense Logistics Agency awarded a delivery order valued at $7,748.39 to AmerisourceBergen Drug Corp for the supply of Erleada 240 mg tablets (30-count units) on December 15, 2025. This firm fixed-price delivery order, which is expected to be completed by January 7, 2026, represents a non-competitively set-aside award and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen Drug Corp's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $7,748.39 delivery order to AmerisourceBergen Drug Corp for 30 tablets of Erleada 240 mg, with a completion deadline of January 22, 2026. This is a firm fixed price contract with no set-aside designation, issued competitively to the pharmaceutical distributor's Corporate Office location in Conshohocken, Pennsylvania. The award represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a $14.24K delivery order to AmerisourceBergen Drug Corp on November 3, 2025, for the supply of Erleada 240 mg tablets in quantities of 30 units. This is a firm fixed price, non-set-aside delivery order with an ultimate completion date of November 25, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a $7,558.78 delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Erleada 60 mg tablets (120 count). This firm fixed price contract, with an ultimate completion date of August 18, 2025, represents a non-set-aside competitive award. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency awarded a delivery order valued at $7,558.78 to AmerisourceBergen Drug Corp for Erleada 60 mg tablets (120 count) on September 2, 2025, with an ultimate completion date of September 23, 2025. This firm fixed price delivery order represents a non-competitive, non-set-aside award under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical. The contract will be performed at AmerisourceBergen's corporate headquarters in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Erleada 240 mg tablets in quantities of 30 units. This competitively awarded, non-set-aside contract carries a ceiling value of $7,352.49 and employs firm fixed pricing. Performance will be completed at AmerisourceBergen's facility in Conshohocken, Pennsylvania, with an ultimate completion date of August 13, 2025. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $7,352.49 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Erleada 240 mg tablets (30-count units) with a completion deadline of November 19, 2025. This non-set-aside competitive award reflects the company's established capability to meet federal pharmaceutical procurement requirements. The award is issued under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX...
- SPE2DR25D3303Indefinite Delivery Contract
- SPE2DR25D3303-SPE2DR26F65M3Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $23,245.17 to AmerisourceBergen Drug Corp for the supply of Erleada 240 mg tablets (30-count units) with a firm fixed-price contract structure. The award was made on January 13, 2026, with an ultimate completion date of February 4, 2026, and represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor, with its parent organization being Cencora, Inc. (doing business as AmerisourceBergen). This delivery order is issued under a significantly larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2026, which authorizes comprehensive pharmaceutical supply across multiple therapeutic domains to support military healthcare systems globally. AmerisourceBergen's IDC with DLA encompasses a broad range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, and medical devices. The company has demonstrated consistent capability in fulfilling federal medical procurement requirements through multiple competitive awards, serving critical healthcare needs for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. This delivery order for Erleada, a prescription oncology medication, exemplifies the company's role in providing essential pharmaceutical commodities to support military treatment facilities and veteran healthcare programs. The non-set-aside competitive award status reflects AmerisourceBergen's ability to compete effectively against other qualified pharmaceutical distributors in the open marketplace for federal contracts.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $23.2k | 1/12/26 |